XSHE000755
Market cap948mUSD
Jan 14, Last price
4.74CNY
1D
2.16%
1Q
1.72%
Jan 2017
-42.55%
Name
Shanxi Sanwei Group Co.
Chart & Performance
Profile
Shanxi Road & Bridge Co.,Ltd. manufactures and sells organic chemical products primarily in the People's Republic of China. Its products include VAE and white emulsions; re-dispersible emulsion powders; sodium diacetate; gamma butyrolactone; poly tetra methylene glycol; tetrahydrofuran; 1,4-butanediol; polyvinyl alcohol; and binder, benzene, coke, and maleic anhydride products. The company serves textile, building and construction, wood process, pharmaceutical, food, tannery, paint coats, and agriculture industries. It also exports its products to approximately 100 countries worldwide. The company was formerly known as Shanxi Sanwei Group Co.,Ltd. Shanxi Road & Bridge Co.,Ltd. was founded in 1970 and is headquartered in Linfen, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,711,646 6.08% | 1,613,501 -2.89% | |||||||
Cost of revenue | 855,675 | 771,315 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 855,971 | 842,187 | |||||||
NOPBT Margin | 50.01% | 52.20% | |||||||
Operating Taxes | 151,859 | 125,980 | |||||||
Tax Rate | 17.74% | 14.96% | |||||||
NOPAT | 704,112 | 716,207 | |||||||
Net income | 458,735 -0.01% | 458,761 12.99% | |||||||
Dividends | (345,716) | ||||||||
Dividend yield | 5.13% | ||||||||
Proceeds from repurchase of equity | (178,533) | ||||||||
BB yield | 2.65% | ||||||||
Debt | |||||||||
Debt current | 303,889 | ||||||||
Long-term debt | 6,635,665 | 6,775,277 | |||||||
Deferred revenue | 1,959 | 2,449 | |||||||
Other long-term liabilities | 42,196 | 123,496 | |||||||
Net debt | 5,797,592 | 6,484,617 | |||||||
Cash flow | |||||||||
Cash from operating activities | 1,170,558 | 1,212,140 | |||||||
CAPEX | (26,369) | ||||||||
Cash from investing activities | (25,990) | ||||||||
Cash from financing activities | (946,589) | ||||||||
FCF | 411,199 | 597,086 | |||||||
Balance | |||||||||
Cash | 838,073 | 594,548 | |||||||
Long term investments | 2 | 1 | |||||||
Excess cash | 752,491 | 513,873 | |||||||
Stockholders' equity | 1,908,790 | 1,747,003 | |||||||
Invested Capital | 10,870,063 | 11,067,857 | |||||||
ROIC | 6.42% | 6.41% | |||||||
ROCE | 7.36% | 7.27% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,467,481 | 1,467,310 | |||||||
Price | 4.59 -15.16% | 5.41 17.10% | |||||||
Market cap | 6,735,739 -15.15% | 7,938,148 26.19% | |||||||
EV | 12,533,331 | 14,422,766 | |||||||
EBITDA | 1,445,019 | 1,373,675 | |||||||
EV/EBITDA | 8.67 | 10.50 | |||||||
Interest | 252,667 | 288,988 | |||||||
Interest/NOPBT | 29.52% | 34.31% |